AYTU BIOPHARMA, INC Increase (Decrease) in Employee Related Liabilities
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Employee Related Liabilities of $3.26 million for the 9-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2021-05-17
- AYTU BIOPHARMA, INC increase (decrease) in employee related liabilities for the quarter ending 2021-03-31 was $3.84M, a 1048.87% increase year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in employee related liabilities for the quarter ending 2020-03-31 was $334.29K.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month |
|---|---|---|---|
| 2021-03-31 | $3.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $3.26M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$576.82K 10-Q · filed 2021-02-11 | ||
| 2020-03-31 | $334.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $271.56K 10-Q · filed 2021-05-17 | |
| 2019-12-31 | -$62.73K 10-Q · filed 2021-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |